Nscale’s $2 Billion Series C: The $14.6bn Bet That Could Reshape AI, Britain and the Future of the NHS
London-based Nscale has secured a $2 billion Series C funding round, propelling the company to a $14.6 billion valuation.
By
Distilled Post Editorial Team